Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of the combination of CHOP plus
daclizumab in patients with ATLL previously untreated with anthracycline based chemotherapy.